Q2 2018 13F Holders as of 6/30/2018
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
63.6M
-
Number of holders
-
84
-
Total 13F shares, excl. options
-
31M
-
Shares change
-
+6.72M
-
Total reported value, excl. options
-
$966M
-
Value change
-
+$213M
-
Number of buys
-
72
-
Number of sells
-
-11
-
Price
-
$31.26
Significant Holders of RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) as of Q2 2018
88 filings reported holding RYTM - RHYTHM PHARMACEUTICALS, INC. - COM as of Q2 2018.
RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) has 84 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31M shares
of 63.6M outstanding shares and own 48.79% of the company stock.
Largest 10 shareholders include NEA Management Company, LLC (4.91M shares), TRV GP, LLC (3.98M shares), MPM ASSET MANAGEMENT LLC (3.07M shares), BAKER BROS. ADVISORS LP (2.71M shares), JANUS HENDERSON GROUP PLC (2.29M shares), ORBIMED ADVISORS LLC (2.07M shares), FMR LLC (1.83M shares), RA CAPITAL MANAGEMENT, LLC (1.54M shares), VANGUARD GROUP INC (933K shares), and PERCEPTIVE ADVISORS LLC (801K shares).
This table shows the top 84 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.